Efficacy of the EGFr inhibitor Iressa on development of chemically-induced urinary bladder cancers: Dose dependency and modulation of biomarkers

Ronald A. Lubet, Yan Lu, Ann M. Bode, Ming You, Zoe M. Verney, Vernone E. Steele, Reid Townsend, M. Margaret Juliana, Clinton J. Grubbs

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint Dive into the research topics of 'Efficacy of the EGFr inhibitor Iressa on development of chemically-induced urinary bladder cancers: Dose dependency and modulation of biomarkers'. Together they form a unique fingerprint.

Medicine & Life Sciences